December
Release time:
2023-05-18
Source:
At the 10th Medical Observer Emerging Forum and the National Medical Elite Club Annual Meeting held in Chongqing on December 3, Jianfeng Pharmaceutical won the "2019 Most Brand Value Pharmaceutical Industry Enterprise" award, and the product Berunning (Olopatadine Hydrochloride Eye Drops) won the "2019 Most Concerned Consistency Evaluation Variety Award".
On December 13, the Shanghai Securities News held the "2019 Listed Companies High-quality Development Forum" and the "Golden quality" award ceremony. Jianfeng Group won the "Golden quality" sustained growth Award of listed companies on the Shanghai Stock Exchange. Jinhua is the only listed company to win this award.
Anhui Jianfeng Beika Pharmaceutical and Anhui Zhongwang Pharmaceutical Phase II Project laid the foundation.
Jianfeng Group was listed as one of the "Top 100 Building Materials Enterprises in China in 2019".
Jianfeng Group passed the second-stage acceptance of the "three" cultivation pilot enterprises organized by the relevant competent departments of Zhejiang Province, and the work related to the "three" project was successfully completed.
Peak put high-speed rail title advertisement through bidding. On January 2, 2020, the "Jianfeng Group" high-speed railway between Shanghai and Kunming was launched at Kunming South Railway Station.
RELATED INFORMATION
22
2023
/
05
22
2023
/
05
22
2023
/
05